42 related articles for article (PubMed ID: 28963820)
1. Genome-wide somatic mutation analysis of sinonasal adenocarcinoma with and without wood dust exposure.
Sipilä LJ; Katainen R; Aavikko M; Ravantti J; Donner I; Lehtonen R; Leivo I; Wolff H; Holmila R; Husgafvel-Pursiainen K; Aaltonen LA
Genes Environ; 2024 May; 46(1):12. PubMed ID: 38711096
[TBL] [Abstract][Full Text] [Related]
2. Programmed death ligand-1 expression as immunotherapeutic target in sinonasal cancer.
Riobello C; Vivanco B; Reda S; López-Hernández A; García-Inclán C; Potes-Ares S; Cabal VN; López F; Llorente JL; Hermsen MA
Head Neck; 2018 Apr; 40(4):818-827. PubMed ID: 29356178
[TBL] [Abstract][Full Text] [Related]
3. CD8
García-Marín R; Reda S; Riobello C; Cabal VN; Suárez-Fernández L; Vivanco B; López F; Llorente JL; Hermsen MA
Vaccines (Basel); 2020 Apr; 8(2):. PubMed ID: 32353928
[TBL] [Abstract][Full Text] [Related]
4. Intestinal-type adenocarcinoma of the sinonasal tract: an update.
Rampinelli V; Ferrari M; Nicolai P
Curr Opin Otolaryngol Head Neck Surg; 2018 Apr; 26(2):115-121. PubMed ID: 29389737
[TBL] [Abstract][Full Text] [Related]
5. Sinonasal cancer in the Italian national surveillance system: Epidemiology, occupation, and public health implications.
Binazzi A; Corfiati M; Di Marzio D; Cacciatore AM; Zajacovà J; Mensi C; Galli P; Miligi L; Calisti R; Romeo E; Franchi A; Marinaccio A
Am J Ind Med; 2018 Mar; 61(3):239-250. PubMed ID: 29114957
[TBL] [Abstract][Full Text] [Related]
6. IDH2 Mutation Analysis in Undifferentiated and Poorly Differentiated Sinonasal Carcinomas for Diagnosis and Clinical Management.
Riobello C; López-Hernández A; Cabal VN; García-Marín R; Suárez-Fernández L; Sánchez-Fernández P; Vivanco B; Blanco V; López F; Franchi A; Llorente JL; Hermsen MA
Am J Surg Pathol; 2020 Mar; 44(3):396-405. PubMed ID: 31876581
[TBL] [Abstract][Full Text] [Related]
7. Tumor Markers and Their Prognostic Value in Sinonasal ITAC/Non-ITAC.
Veuger J; Kuipers NC; Willems SM; Halmos GB
Cancers (Basel); 2023 Jun; 15(12):. PubMed ID: 37370810
[TBL] [Abstract][Full Text] [Related]
8. Personalized Medicine in Skull Base and Sinonasal Tumors.
Mattavelli D; Bossi P
J Pers Med; 2022 Dec; 12(12):. PubMed ID: 36556204
[TBL] [Abstract][Full Text] [Related]
9. The contemporary management of cancers of the sinonasal tract in adults.
Thawani R; Kim MS; Arastu A; Feng Z; West MT; Taflin NF; Thein KZ; Li R; Geltzeiler M; Lee N; Fuller CD; Grandis JR; Floudas CS; Heinrich MC; Hanna E; Chandra RA
CA Cancer J Clin; 2023 Jan; 73(1):72-112. PubMed ID: 35916666
[TBL] [Abstract][Full Text] [Related]
10. Towards a Molecular Classification of Sinonasal Carcinomas: Clinical Implications and Opportunities.
Taverna C; Agaimy A; Franchi A
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326613
[TBL] [Abstract][Full Text] [Related]
11. MiRNome analysis identifying miR-205 and miR-449a as biomarkers of disease progression in intestinal-type sinonasal adenocarcinoma.
Re M; Tomasetti M; Monaco F; Amati M; Rubini C; Sollini G; Bajraktari A; Gioacchini FM; Santarelli L; Pasquini E
Head Neck; 2022 Jan; 44(1):18-33. PubMed ID: 34647653
[TBL] [Abstract][Full Text] [Related]
12. Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma.
Riobello C; Sánchez-Fernández P; Cabal VN; García-Marín R; Suárez-Fernández L; Vivanco B; Blanco-Lorenzo V; Álvarez Marcos C; López F; Llorente JL; Hermsen MA
Cancers (Basel); 2021 Oct; 13(19):. PubMed ID: 34638506
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing for identification of actionable gene mutations in intestinal-type sinonasal adenocarcinoma.
Sánchez-Fernández P; Riobello C; Costales M; Vivanco B; Cabal VN; García-Marín R; Suárez-Fernández L; López F; Cabanillas R; Hermsen MA; Llorente JL
Sci Rep; 2021 Jan; 11(1):2247. PubMed ID: 33500480
[TBL] [Abstract][Full Text] [Related]
14. Novel Biomarkers in Sinonasal Cancers: from Bench to Bedside.
Lechner M; Liu J; Lund VJ
Curr Oncol Rep; 2020 Jul; 22(10):106. PubMed ID: 32725435
[TBL] [Abstract][Full Text] [Related]
15. Management of sinonasal adenocarcinomas with anterior skull base extension.
Ferrari M; Bossi P; Mattavelli D; Ardighieri L; Nicolai P
J Neurooncol; 2020 Dec; 150(3):405-417. PubMed ID: 31897925
[TBL] [Abstract][Full Text] [Related]
16. Nasoethmoidal Intestinal-Type Adenocarcinoma Treated with Cetuximab: Role of Liquid Biopsy and BEAMing in Predicting Response to Anti-Epidermal Growth Factor Receptor Therapy.
Cabezas-Camarero S; de la Orden García V; García-Barberán V; Mediero-Valeros B; Subhi-Issa AI; Llovet García P; Bando-Polaino I; Merino Menéndez S; Pérez-Segura P; Díaz-Rubio E
Oncologist; 2019 Mar; 24(3):293-300. PubMed ID: 30602616
[TBL] [Abstract][Full Text] [Related]
17. Genomic profiling of intestinal-type sinonasal adenocarcinoma reveals subgroups of patients with distinct clinical outcomes.
López-Hernández A; Pérez-Escuredo J; Vivanco B; García-Inclán C; Potes-Ares S; Cabal VN; Riobello C; Costales M; López F; Llorente JL; Hermsen MA
Head Neck; 2018 Feb; 40(2):259-273. PubMed ID: 28963820
[TBL] [Abstract][Full Text] [Related]
18. Recurrent DNA copy number alterations in intestinal-type sinonasal adenocarcinoma.
Perez-Escuredo J; Lopez-Hernandez A; Costales M; Lopez F; Ares SP; Vivanco B; Llorente JL; Hermsen MA
Rhinology; 2016 Sep; 54(3):278-86. PubMed ID: 27107016
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
